BC5 illustrated areas of DCIS within an invasive ductal breast carcinoma of NST and was diagnosed as negative for ERa/PR and classified as triple negative, after a dubious HER2 (weak positivity) IHC, and negativity for HER2 FISH (Table S1). This evidence concerns the gene ESR1 and ductal breast carcinoma in situ.